Neurocrine Biosciences (NBIX) Tops Q3 EPS by 29c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 146.10 -0.28 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.38 | 52 Week High | $58.46 | |||
| Open | $147.13 | 52 Week Low | $31.25 | |||
| Day High | $149.25 | P/E | N/A | |||
| Day Low | $145.22 | EPS | $-0.69 | |||
| Volume | 1,322,281 | |||||
